|
Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 126 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Mantle Cell Lymphoma clinical trial scenario. This report provides.....
Introduction GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Mantle Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mantle Cell Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mantle Cell Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Mantle Cell Lymphoma 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Mantle Cell Lymphoma 25 Subjects Recruited Over a Period of Time 28 Prominent Sponsors 29 Top Companies Participating in Mantle Cell Lymphoma Therapeutics Clinical Trials 31 Prominent Drug Comparison 33 Clinical Trial Profiles 34 Clinical Trial Overview of Top Companies 34 Pfizer Inc. 34 Clinical Trial Overview of Pfizer Inc. 34 SymBio Pharmaceuticals Limited 35 Clinical Trial Overview of SymBio Pharmaceuticals Limited 35 Takeda Pharmaceutical Company Limited 36 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36 Celgene Corporation 37 Clinical Trial Overview of Celgene Corporation 37 Cephalon, Inc. 38 Clinical Trial Overview of Cephalon, Inc. 38 F. Hoffmann-La Roche Ltd. 39 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39 Sanofi 40 Clinical Trial Overview of Sanofi 40 Amgen Inc. 41 Clinical Trial Overview of Amgen Inc. 41 BioMarin Pharmaceutical Inc. 42 Clinical Trial Overview of BioMarin Pharmaceutical Inc. 42 Novartis AG 43 Clinical Trial Overview of Novartis AG 43 Merck & Co., Inc. 44 Clinical Trial Overview of Merck & Co., Inc. 44 Pharmacyclics, Inc. 45 Clinical Trial Overview of Pharmacyclics, Inc. 45 Piramal Life Sciences Limited 46 Clinical Trial Overview of Piramal Life Sciences Limited 46 Telik, Inc. 47 Clinical Trial Overview of Telik, Inc. 47 MethylGene Inc 48 Clinical Trial Overview of MethylGene Inc 48 Celldex Therapeutics, Inc. 49 Clinical Trial Overview of Celldex Therapeutics, Inc. 49 Onyx Pharmaceuticals, Inc. 50 Clinical Trial Overview of Onyx Pharmaceuticals, Inc. 50 Sunesis Pharmaceuticals, Inc. 51 Clinical Trial Overview of Sunesis Pharmaceuticals, Inc. 51 GlaxoSmithKline plc 52 Clinical Trial Overview of GlaxoSmithKline plc 52 Millennium Pharmaceuticals, Inc. 53 Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 53 Clinical Trial Overview of Top Universities / Institutes / Hospitals 54 Fred Hutchinson Cancer Research Center 54 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54 The University of Texas M. D. Anderson Cancer Center 56 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56 Mayo Clinic 57 Clinical Trial Overview of Mayo Clinic 57 Weill Cornell Medical College 58 Clinical Trial Overview of Weill Cornell Medical College 58 Stanford University 59 Clinical Trial Overview of Stanford University 59 Duke University 60 Clinical Trial Overview of Duke University 60 Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 61 Clinical Trial Overview of Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 61 City of Hope National Medical Center 62 Clinical Trial Overview of City of Hope National Medical Center 62 University of Wisconsin Madison 63 Clinical Trial Overview of University of Wisconsin Madison 63 Massachusetts General Hospital 64 Clinical Trial Overview of Massachusetts General Hospital 64 H. Lee Moffitt Cancer Center & Research Institute 65 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 65 University of Pennsylvania 66 Clinical Trial Overview of University of Pennsylvania 66 Case Comprehensive Cancer Center 67 Clinical Trial Overview of Case Comprehensive Cancer Center 67 Wake Forest University 68 Clinical Trial Overview of Wake Forest University 68 Southwest Oncology Group 69 Clinical Trial Overview of Southwest Oncology Group 69 Ohio State University Comprehensive Cancer Center 70 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 70 Groupe d'Etudes de Lymphomes de L'Adulte 71 Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte 71 Memorial Sloan-Kettering Cancer Center 72 Clinical Trial Overview of Memorial Sloan-Kettering Cancer Center 72 Thomas Jefferson University 73 Clinical Trial Overview of Thomas Jefferson University 73 University Hospital, Bordeaux 74 Clinical Trial Overview of University Hospital, Bordeaux 74 Five Key Clinical Profiles 75 Appendix 123 Abbreviations 123 Definitions 123 Research Methodology 124 Secondary Research 124 About GlobalData 125 Contact Us 125 Disclaimer 125 Source 126 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Mantle Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Mantle Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Mantle Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Mantle Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15 Mantle Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Mantle Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Mantle Cell Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 18 Mantle Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Mantle Cell Lymphoma Therapeutics Clinical Trials, E7 Countries, 2012* 20 Mantle Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Mantle Cell Lymphoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Mantle Cell Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Mantle Cell Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012* 35 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 36 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 37 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 38 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 39 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 40 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 41 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2012* 42 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 43 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 44 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 45 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Piramal Life Sciences Limited, 2012* 46 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2012* 47 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc, 2012* 48 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2012* 49 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Onyx Pharmaceuticals, Inc., 2012* 50 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunesis Pharmaceuticals, Inc., 2012* 51 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 52 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 53 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 54 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 56 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 57 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 58 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 59 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 60 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 61 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 62 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 63 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 64 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 65 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 66 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 67 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 68 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 69 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 70 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2012* 71 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan-Kettering Cancer Center, 2012* 72 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 73 Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2012* 74 List of Figures Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Mantle Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Mantle Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Mantle Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Mantle Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15 Mantle Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Mantle Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Mantle Cell Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Mantle Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Mantle Cell Lymphoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Mantle Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 GlobalData Methodology 124 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
